Literature DB >> 8150970

Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.

K Miwa1, M Fukuyama, T Kunitomo, H Igarashi.   

Abstract

A noncompetitive enzyme-linked immunosorbent assay that enables the quantitation of toxic shock syndrome toxin 1 (TSST-1) to as little as 30 pg/ml and the detection of TSST-1 to 10 pg/ml in phosphate-buffered saline including 33% human serum or plasma was developed. It takes only 3 h to complete this assay after plate preparation. In this study, 64 human serum samples obtained from 30 patients with toxic shock syndrome or toxic shock syndrome-like symptoms were subjected to testing for the detection of TSST-1. With a cutoff level for TSST-1 of less than 100 pg/ml, 28 samples obtained from 12 patients were positive for TSST-1. The mean and maximum concentrations for these TSST-1-positive samples were 440 and 5,450 pg/ml, respectively. Of these 12 patients, 8 were Staphylococcus aureus culture positive, 3 were negative upon bacterial culturing, and 1 had no cultures done.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150970      PMCID: PMC263072          DOI: 10.1128/jcm.32.2.539-542.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.

Authors:  H Igarashi; H Fujikawa; M Shingaki; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

2.  Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1.

Authors:  J Parsonnet; J T Mills; Z A Gillis; G B Pier
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

3.  Purification and some physicochemical properties of toxic-shock toxin.

Authors:  R F Reiser; R N Robbins; G P Khoe; M S Bergdoll
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

4.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus.

Authors:  L S Weckbach; M R Thompson; J L Staneck; P F Bonventre
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

6.  Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.

Authors:  D A Blomster-Hautamaa; R P Novick; P M Schlievert
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

7.  Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.

Authors:  J C de Azavedo; J P Arbuthnott
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins.

Authors:  H Igarashi; H Fujikawa; H Usami; S Kawabata; T Morita
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more
  6 in total

1.  Development and evaluation of detection systems for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome.

Authors:  S Ladhani; S Robbie; R C Garratt; D S Chapple; C L Joannou; R W Evans
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 2.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  A fatal postpartum Clostridium sordellii associated toxic shock syndrome.

Authors:  A Bitti; P Mastrantonio; P Spigaglia; G Urru; A I Spano; G Moretti; G B Cherchi
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

4.  [Special features of intensive care of toxic shock syndrome. Review and case report of a TSST-1 associated toxic-shock syndrome with adult respiratory distress syndrome and multiple organ failure from a staphylococcal panaritium].

Authors:  C Lang; H Behnke; J Bittersohl; L Eberhart; E Walthers; F Sommer; H Wulf; G Geldner
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

5.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

6.  Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.

Authors:  Sacha Flammier; Jean-Philippe Rasigade; Cédric Badiou; Thomas Henry; François Vandenesch; Frédéric Laurent; Sophie Trouillet-Assant
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.